Delaware § 3554 Lead poison screening reimbursement [For application of this section, see 83 Del. Laws, c. 75, § 9]

Delaware Statutes

§ 3554 — Lead poison screening reimbursement [For application of this section, see 83 Del. Laws, c. 75, § 9]

Delaware § 3554

JurisdictionDelaware

Title18

PartInsurance

Ch. 35GROUP AND BLANKET HEALTH INSURANCE

Subch.Provisions Applicable to Group and Blanket Health Insurance

This text of Delaware § 3554 (Lead poison screening reimbursement [For application of this section, see 83 Del. Laws, c. 75, § 9]) is published on Counsel Stack Legal Research, covering Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Del. Code tit. 18, § 3554 (2026).

Text

(a)All group and blanket insurance policies, which are delivered or issued for delivery in this State by any health insurer, health service corporation, health maintenance organization, or any health services and facilities reimbursement program operated by the State which provide a benefit for outpatient services shall provide a benefit for a baseline lead poisoning screening or testing, as defined in § 2601 of Title 16.

(b)Benefits must also be provided for lead poisoning screening, testing, diagnostic evaluations, screening and testing supplies, and home visits for children who are at high risk for lead poisoning under guidelines and criteria established by the Division of Public Health.

(c)The benefits required under subsections (a) and (b) of this section are a covered service, n

Free access — add to your briefcase to read the full text and ask questions with AI

(a) All group and blanket insurance policies, which are delivered or issued for delivery in this State by any health insurer, health service corporation, health maintenance organization, or any health services and facilities reimbursement program operated by the State which provide a benefit for outpatient services shall provide a benefit for a baseline lead poisoning screening or testing, as defined in § 2601 of Title 16.

(b) Benefits must also be provided for lead poisoning screening, testing, diagnostic evaluations, screening and testing supplies, and home visits for children who are at high risk for lead poisoning under guidelines and criteria established by the Division of Public Health.

(c) The benefits required under subsections (a) and (b) of this section are a covered service, notwithstanding any policy exclusions for services which are part of, or related to, annual or routine examinations.

(d) Nothing in this section prevents the operation of policy provisions such as deductibles, coinsurance allowable charge limitations, coordination of benefits, or provision restricting coverage to services rendered by licensed, certified, or carrier-approved providers or facilities.

(e) This section does not apply to accident-only, specified disease, hospital indemnity, Medicare supplement, long-term care, or other limited health insurance policies.